Positron emission tomography in non-medullary thyroid cancer

被引：3
|
作者：
Shon, Ivan Ho [1 ,4 ,5 ]
Depcynzski, Barbara [1 ,3 ]
Lin, Michael [1 ,4 ,5 ]
Clark, Jonathan R. [2 ]
Wong, Vincent [1 ,3 ]
Lin, Peter [4 ,5 ]
Campbell, Peter [2 ]
机构：
[1] Univ New S Wales, S Western Clin Sch, Sydney, NSW, Australia
[2] Liverpool Hosp, Dept Surg, Liverpool, Merseyside, England
[3] Liverpool Hosp, Diabet & Endocrine Serv, Liverpool, Merseyside, England
[4] Liverpool Hosp, Dept Nucl Med, Liverpool, Merseyside, England
[5] Liverpool Hosp, PET, Liverpool, Merseyside, England
来源：
ANZ JOURNAL OF SURGERY | 2011年 / 81卷 / 03期
关键词：
fluoro-deoxy glucose; positron emission tomography; thyroid neoplasm; thyroid nodule; ELEVATED SERUM THYROGLOBULIN; WHOLE-BODY SCANS; F-18 FDG PET/CT; FOLLOW-UP; RADIOACTIVE IODINE; CARCINOMA PATIENTS; GLUCOSE-TRANSPORT; THYROTROPIN STIMULATION; DIAGNOSTIC-ACCURACY; THERAPEUTIC IMPACT;
D O I：
10.1111/j.1445-2197.2010.05538.x
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
While iodine scanning is the mainstay of functional imaging in differentiated thyroid cancer, there is now a significant body of literature regarding positron emission tomography with 2-fluoro-2-deoxy glucose in thyroid cancer. This clinical review will examine the evidence supporting the use of 2-fluoro-2-deoxy glucose-positron emission tomography throughout the diagnosis and management of thyroid cancer, and provide suggestions for its clinical use and potential future roles.
引用
收藏
页码：116 / 124
页数：9
相关论文
共 50 条
  • [21] Ubiquitination default as a familial non-medullary thyroid cancer marker
    Fernandes, C.
    Teixeira, E.
    Gaspar, T.
    Canberk, S.
    Batista, R.
    Soares, P.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2023, 53
  • [22] Examination of the somatostatin receptor status in non-medullary thyroid cancer
    Görges, R
    Kahaly, G
    Müller-Brand, J
    Mäcke, H
    Walgenbach, S
    Bruns, C
    Andreas, J
    Brandt-Mainz, K
    Bockisch, A
    NUKLEARMEDIZIN, 1999, 38 (01) : 15 - 23
  • [23] Significance of RAS Mutations in Thyroid Benign Nodules and Non-Medullary Thyroid Cancer
    Marotta, Vincenzo
    Bifulco, Maurizio
    Vitale, Mario
    CANCERS, 2021, 13 (15)
  • [24] Positron emission tomography of the thyroid, with an emphasis on thyroid cancer
    Mcdougall, IR
    Davidson, J
    Segall, GM
    NUCLEAR MEDICINE COMMUNICATIONS, 2001, 22 (05) : 485 - 492
  • [25] Familial forms of non-medullary thyroid carcinoma
    Leite, Tiago
    Pimenta, Tiago
    Taveira-Gomes, Antonio
    REVISTA PORTUGUESA DE ENDOCRINOLOGIA DIABETES E METABOLISMO, 2014, 9 (02) : 106 - 110
  • [26] Positron Emission Tomography/Computed Tomography in Thyroid Cancer
    Bal, Chandrasekhar
    Chakraborty, Dhritiman
    Khan, Dikhra
    PET CLINICS, 2022, 17 (02) : 265 - 283
  • [27] Familial non-medullary thyroid cancer: clinical features and molecular analysis
    Forde, Claire
    Fussey, John
    Hartley, Claire
    Burghel, George
    Hoffman, John
    Adlard, Julian
    Lalloo, Fiona
    Side, Lucy
    Morrison, Patrick J.
    Smith, Joel
    Dyer, Sara
    Ayuso, Inigo Ortiz de Mendibil
    Lim, Derek
    Evans, Dafydd G. R.
    Maher, Eamonn R.
    Woodward, Emma R.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2022, 30 (SUPPL 1) : 416 - 416
  • [28] Familial non-medullary thyroid cancer: A family of four with 100% penetrance
    Harwick, RD
    Leech, SH
    Rubenstein, WS
    Han, XY
    17TH INTERNATIONAL CANCER CONGRESS, VOL 1 AND 2, 1998, : 561 - 565
  • [29] Non-medullary Thyroid Cancer Susceptibility Genes: Evidence and Disease Spectrum
    Jingan Zhou
    Preeti Singh
    Kanhua Yin
    Jin Wang
    Yujia Bao
    Menghua Wu
    Kush Pathak
    Sophia K. McKinley
    Danielle Braun
    Carrie C. Lubitz
    Kevin S. Hughes
    Annals of Surgical Oncology, 2021, 28 : 6590 - 6600
  • [30] Familial Non-Medullary Thyroid Carcinoma: An Update
    Vânia Nosé
    Endocrine Pathology, 2008, 19 : 226 - 240
12345